Attached files
| file | filename |
|---|---|
| 10-K - SKYSTAR BIO-PHARMACEUTICAL CO | v179475_10k.htm |
| EX-32.2 - SKYSTAR BIO-PHARMACEUTICAL CO | v179475_ex32-2.htm |
| EX-31.2 - SKYSTAR BIO-PHARMACEUTICAL CO | v179475_ex31-2.htm |
| EX-99.6 - SKYSTAR BIO-PHARMACEUTICAL CO | v179475_ex99-6.htm |
| EX-31.1 - SKYSTAR BIO-PHARMACEUTICAL CO | v179475_ex31-1.htm |
| EX-10.17 - SKYSTAR BIO-PHARMACEUTICAL CO | v179475_ex10-17.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO
18 U.S.C.
SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the annual report of Skystar Bio-Pharmaceutical Company, (the
“Company”) on Form 10-K for the year ending December 31, 2009 as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), I, Weibing
Lu, Chief Executive Officer of the Company, hereby certify as of the date
hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United
States Code, that to the best of my knowledge:
(1) The
Report fully complies with the requirements of section 13 (a) or 15 (d), as
applicable, of the Securities Exchange Act of 1934, as amended; and
(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and result of operations of the Company at the dates and
for the periods indicated.
|
/s/
Weibing Lu
|
||
|
Weibing
Lu
Chief
Executive Officer
March
31, 2010
|
A signed
original of this written statement required by Section 906 has been provided to
the Company and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.